Key result
A 5-variable ACHD risk model showed good external discrimination and calibration for predicting 1-year death, heart failure, or arrhythmia.
Cohort (n=1,351)
Yes
Answers are grounded in this paper and cite their sources.
AIMS: Adequate risk prediction can optimize the clinical management in adult congenital heart disease (ACHD). We aimed to update and subsequently validate a previously developed ACHD risk prediction model. METHODS AND RESULTS: A prediction model was developed in a prospective cohort study including 602 moderately or severely complex ACHD patients, enrolled as outpatients at a tertiary centre in the Netherlands (2011-2013). Multivariable Cox regression was used to develop a model for predicting the 1-year risks of death, heart failure (HF), or arrhythmia (primary endpoint). The Boston ACHD Biobank study, a prospectively enrolled cohort (n = 749) of outpatients who visited a referral centre in Boston (2012-2017), was used for external validation. The primary endpoint occurred in 153 (26%) and 191 (28%) patients in the derivation and validation cohorts over median follow-up of 5.6 and 2.3 years, respectively. The final model included 5 out of 14 pre-specified predictors with the following hazard ratios; New York Heart Association class ≥II: 1.92 [95% confidence interval (CI) 1.28-2.90], cardiac medication 2.52 (95% CI 1.72-3.69), ≥1 reintervention after initial repair: 1.56 (95% CI 1.09-2.22), body mass index: 1.04 (95% CI 1.01-1.07), log2 N-terminal pro B-type natriuretic peptide (pmol/L): 1.48 (95% CI 1.32-1.65). At external validation, the model showed good discrimination (C-statistic 0.79, 95% CI 0.74-0.83) and excellent calibration (calibration-in-the-large = -0.002; calibration slope = 0.99). CONCLUSION: These data support the validity and applicability of a parsimonious ACHD risk model based on five readily available clinical variables to accurately predict the 1-year risk of death, HF, or arrhythmia. This risk tool may help guide appropriate care for moderately or severely complex ACHD.
No takes yet. Share an insight, caveat, or question.
Geenen et al. (2020) conducted a cohort in Moderately or severely complex adult congenital heart disease (ACHD) (n=1,351). 5-variable ACHD risk prediction model (NYHA class ≥II, cardiac medication, ≥1 reintervention, BMI, log2 NT-proBNP) was evaluated on 1-year risk of death, heart failure (HF), or arrhythmia (C-statistic 0.79, 95% CI 0.74-0.83). A 5-variable ACHD risk model showed good external discrimination and calibration for predicting 1-year death, heart failure, or arrhythmia.
Synapse has enriched 10 related papers. Consider them for comparative context: